Pacira | PCRX - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Assertio Holdings USD 8.89M 2.29M 2024-06
Astellas Pharma JPY 129.43B 19.7B 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 4.04M 324K 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 8.07B 103M 2026-03
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novo Nordisk DKK 13.6B 1.55B 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 50.74M 3.89M 2026-03
Perrigo USD 643.7M 103.7M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Xeris Pharmaceuticals USD 13.66M 49K 2025-12
Xoma 116K 112.7K 2024-06
Zoetis USD 672M 71M 2026-03